For the practice to be safe and effective, several key medical standards have to be met: It requires FDA-approved treatments prescribed strictly by a licensed medical professional
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M
Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality
This is the window that the Finkley 2005 trial captured, and the Carey/Pickart ultrasound work confirmed at the structural level: an average 28% increase in collagen density, with top responders at 51%
The results of this treatment lasts from several weeks to several months based on an individuals metabolism, lifestyle & sun exposure